Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study (scientific article)

Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico

Q21245830

Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States

Q23911285

A new equation to estimate glomerular filtration rate

Q24651973

Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements

Q24814239

Profile of urinary arsenic metabolites during pregnancy

Q24817001

Serine, glycine and one-carbon units: cancer metabolism in full circle

Q26828610

Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review

Q26863666

Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence

Q27027739

Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity

Q28382946

Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh

Q28385521

Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico

Q28387768

Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study

Q28390833

Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina

Q28392195

Arsenic biotransformation as a cancer promoting factor by inducing DNA damage and disruption of repair mechanisms

Q28392983

Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine

Q28396689

Association between maternal folate concentrations during pregnancy and insulin resistance in Indian children

Q28661252

Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians

Q33621139

Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.

Q51171589

Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.

Q51939995

The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure

Q57936718

Transmission of HIV by transfusion of screened blood

Q68593240

Diabetes and coronary heart disease in American Indians: The Strong Heart Study

Q71172661

Interactions between arsenic-induced toxicity and nutrition in early life

Q79923890

Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes

Q80538214

S-adenosylmethionine is associated with fat mass and truncal adiposity in older adults

Q86040942

Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes

Q33891890

Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus

Q33911806

Methylated trivalent arsenic species are genotoxic

Q33942554

Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population

Q34150976

Mechanisms of arsenic biotransformation

Q34167496

Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes

Q34336096

Cardiovascular epigenetics: basic concepts and results from animal and human studies

Q34537250

Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence

Q34603034

Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms.

Q35079230

Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid.

Q35791041

Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The Strong Heart Study

Q35840910

Arsenic species and selected metals in human urine: validation of HPLC/ICPMS and ICPMS procedures for a long-term population-based epidemiological study.

Q36012023

S-adenosylmethionine-dependent protein methylation is required for expression of selenoprotein P and gluconeogenic enzymes in HepG2 human hepatocytes

Q36332941

Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study

Q36764977

A C. elegans model to study human metabolic regulation

Q36794404

Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets

Q36895189

Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology.

Q36927018

Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes

Q37188943

A population-based case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA.

Q37241094

A review on environmental factors regulating arsenic methylation in humans.

Q37376965

Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study

Q37444401

A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans

Q39451299

Arsenic induces pancreatic β-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathways.

Q39622017

Recruitment of American Indians in epidemiologic research: the Strong Heart Study

Q40715675

The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods

Q41174948

Adjustment for total energy intake in epidemiologic studies

Q41421234

Elevated S-adenosylhomocysteine alters adipocyte functionality with corresponding changes in gene expression and associated epigenetic marks

Q42454864

Arsenic methylation and bladder cancer risk in Taiwan

Q43516390

Pregnancy and the methyltransferase genotype independently influence the arsenic methylation phenotype

Q43906923

A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus

Q44367165

Arsenic methylation capacity and skin cancer.

Q45973504

Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan

Q46136200

Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.

Q46615430

Occurrence of trivalent monomethyl arsenic and other urinary arsenic species in a highly exposed juvenile population in Bangladesh.

Q46633230

Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution

Q48694393

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

arsenic

Q871

P304

page(s)

620-627

P577

publication date

2015-01-12

P1433

published in

Diabetes Care

Q5270111

P1476

title

Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study

P478

volume

Reverse relations

cites work (P2860)

Q92586317	A Review of Environmental Epidemiology Studies in Southwestern and Mountain West Rural Minority Populations
Q64275538	A Review of Metal Exposure Studies Conducted in the Rural Southwestern and Mountain West Region of the United States
Q46941914	A dose-response meta-analysis of chronic arsenic exposure and incident cardiovascular disease
Q29248177	Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?
Q89688079	Arsenic disturbs the gut microbiome of individuals in a disadvantaged community in Nepal
Q28387333	Arsenic exposure is associated with diminished insulin sensitivity in non-diabetic Amish adults
Q88642774	Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain
Q35830809	Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism.
Q38799609	Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study
Q57470861	Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study
Q42695376	Association Between Variants in Arsenic (+3 Oxidation State) Methyltranserase (AS3MT) and Urinary Metabolites of Inorganic Arsenic: Role of Exposure Level.
Q49649255	Association of Low-Moderate Arsenic Exposure and Arsenic Metabolism with Incident Diabetes and Insulin Resistance in the Strong Heart Family Study
Q58969794	Association of low-moderate urine arsenic and QT interval: Cross-sectional and longitudinal evidence from the Strong Heart Study
Q93239223	Circulating miRNAs Associated with Arsenic Exposure
Q46120518	Dietary B Vitamin Intake Is Associated with Lower Urinary Monomethyl Arsenic and Oxidative Stress Marker 15-F2t-Isoprostane among New Hampshire Adults.
Q38605998	Environmental factors in cardiovascular disease
Q57942296	Ethnic, Geographic, and Genetic Differences in Arsenic Metabolism at Low Arsenic Exposure: A Preliminary Analysis in the Multi-Ethnic Study of Atherosclerosis (MESA)
Q35978419	Expression of arsenic resistance genes in the obligate anaerobe Bacteroides vulgatus ATCC 8482, a gut microbiome bacterium
Q39282281	Genetic and epigenetic mechanisms underlying arsenic-associated diabetes mellitus: a perspective of the current evidence
Q35844220	Identification of Small Molecule Inhibitors of Human As(III) S-Adenosylmethionine Methyltransferase (AS3MT)
Q48183802	Inorganic arsenic causes fatty liver and interacts with ethanol to cause alcoholic liver disease in zebrafish
Q41691100	Lifestyle precision medicine: the next generation in type 2 diabetes prevention?
Q35908703	MDI Biological Laboratory Arsenic Summit: Approaches to Limiting Human Exposure to Arsenic
Q36785962	Metal mixtures in urban and rural populations in the US: The Multi-Ethnic Study of Atherosclerosis and the Strong Heart Study
Q29249056	Mitigating dietary arsenic exposure: Current status in the United States and recommendations for an improved path forward
Q90544902	One-carbon metabolism nutrient intake and the association between body mass index and urinary arsenic metabolites in adults in the Chihuahua cohort
Q28396309	Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study
Q56547215	Perspectives on Biological Monitoring in Environmental Health Research: A Focus Group Study in a Native American Community
Q48959587	Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway.
Q35952226	Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study
Q57490750	Targeted metabolomics to understand the association between arsenic metabolism and diabetes-related outcomes: Preliminary evidence from the Strong Heart Family Study
Q51244944	The Association of Arsenic Exposure and Arsenic Metabolism with the Metabolic Syndrome and its Individual Components: Prospective Evidence from the Strong Heart Family Study.
Q28397168	The Association of Arsenic Exposure and Metabolism With Type 1 and Type 2 Diabetes in Youth: The SEARCH Case-Control Study
Q38400126	The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence
Q92170097	Transcriptome responses in blood reveal distinct biological pathways associated with arsenic exposure through drinking water in rural settings of Punjab, Pakistan